- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
XOMA Corp (XOMA)
XOMA Corp stock price live, this page displays NASDAQ XOMA stock exchange data. View the XOMA premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the XOMA Corp real time stock price chart below.
What Is the XOMA Corp Stock Price Today?
The XOMA Corp stock price today is 40.86.
What Is the Stock Symbol for XOMA Corp?
The stock symbol for XOMA Corp is "XOMA."
What Stock Exchange Does XOMA Corp Trade On?
XOMA Corp is listed and trades on the NASDAQ stock exchange.
Is XOMA Corp a Good Stock to Buy?
Determining whether XOMA Corp, or any stock, is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the XOMA quote. (ISIN: US98419J2069) Test %CURRENT_YEAR% | %DIVIDEND_YIELD% | %UPSIDE_OR_DOWNSIDE%
What Is the XOMA Corp Stock Price Today?
The XOMA Corp stock price today is 40.86.
What Is the Stock Symbol for XOMA Corp?
The stock symbol for XOMA Corp is "XOMA."
What Stock Exchange Does XOMA Corp Trade On?
XOMA Corp is listed and trades on the NASDAQ stock exchange.
Is XOMA Corp a Good Stock to Buy?
Determining whether XOMA Corp, or any stock, is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the XOMA quote. (ISIN: US98419J2069) Test %CURRENT_YEAR% | %DIVIDEND_YIELD% | %UPSIDE_OR_DOWNSIDE%
NASDAQ
Currency in USD
Fair Value
An estimate of a XOMA's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
40.74
42.10
52 wk Range
22.29
42.81
Unusual trading volume
1/3
Fair Value
An estimate of a XOMA's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
40.7442.10
52 wk Range
22.2942.81
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
XOMA Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a XOMA's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Buy
Price Target
62.00
Upside
+51.74%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Net income is expected to grow this year
- Ligand to acquire XOMA Royalty for $739 million in cash deal
- Investing.com
Pro
- XOMA Ltd receives Investment Bank Analyst Rating Update
- Investing.com
Pro
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Buy
Technical Indicators
Buy
Moving Averages
Buy
XOMA Royalty Corporation operates as a biotech royalty aggregator in the United States, Switzerland, the Asia Pacific, and Australia. It has a portfolio of economic rights to future potential milestone and royalty payments associated with commercial products and pre-commercial therapeutic candidates. The company also focuses on early to mid-stage clinical assets primarily in Phase 1 and 2 with commercial sales potential that are licensed to sponsors or developers; and acquires milestone and royalty revenue streams on late-stage clinical assets and commercial assets. It has a portfolio with various assets. The company was formerly known as XOMA Corporation and changed its name to XOMA Royalty Corporation in July 2024. XOMA Royalty Corporation was incorporated in 1981 and is headquartered in Emeryville, California.
XOMA Corp Earnings Call Summary for Q4/2025
- XOMA Q4 2025 EPS of $0.26 beat forecast of -$0.11 by 336%; revenue reached $13.76M, exceeding estimates by 23.63%
- Full-year revenue surged 82.8% vs 2024; GAAP net income of $31.7M reversed prior year's $13.8M loss; royalty receipts up 68% to $34M
- Stock climbed 5.19% to $28.40 in pre-market trading following the earnings beat, reflecting strong investor confidence
- Company projects continued growth in 2026 driven by diversified portfolio and strategic capital deployment initiatives
- Key risks include ongoing Janssen Biotech litigation and declining cash reserves from strategic investments despite debt reduction efforts
Last Updated: 18/03/2026, 15:18
Read Full TranscriptCompare XOMA to Peers and Sector
Metrics to compare | XOMA | Sector Sector - Average of metrics from a broad group of related Consumer Cyclicals sector companies | Relationship RelationshipXOMAPeersSector | |
|---|---|---|---|---|
P/E Ratio | 26.3x | 0.0x | −0.5x | |
PEG Ratio | 0.14 | −0.38 | 0.00 | |
Price/Book | 5.8x | 2.9x | 2.6x | |
Price / LTM Sales | 9.3x | 12.3x | 3.2x | |
Upside (Analyst Target) | 22.4% | 75.8% | 48.8% | |
Fair Value Upside | Unlock | 11.0% | 7.6% | Unlock |
Analyst Ratings
2 Buy
2 Hold
0 Sell
Ratings:
4 analysts
Overall Consensus
Buy
Analysts 12-Month Price Target:
Average 62.00
(+51.74% Upside)
Earnings
Latest Release
Mar 18, 2026
EPS / Forecast
0.26 / -0.11
Revenue / Forecast
13.76M / 11.13M
People Also Watch
FAQ
What Is the XOMA (XOMA) Stock Price Today?
The XOMA stock price today is 40.86 USD.
What Stock Exchange Does XOMA Trade On?
XOMA is listed and trades on the Nasdaq Stock Exchange.
What Is the Stock Symbol for XOMA?
The stock symbol for XOMA is "XOMA."
What Is the XOMA Market Cap?
As of today, XOMA market cap is 486.88M USD.
What Is XOMA's Earnings Per Share (TTM)?
The XOMA EPS (TTM) is 1.46.
When Is the Next XOMA Earnings Date?
XOMA will release its next earnings report on Apr 30, 2026.
From a Technical Analysis Perspective, Is XOMA a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
How Many Times Has XOMA Stock Split?
XOMA has split 2 times.
How Many Employees Does XOMA Have?
XOMA has 14 employees.
What is the current trading status of XOMA (XOMA)?
As of Apr 29, 2026, XOMA (XOMA) is trading at a price of 40.86 USD, with a previous close of 40.86 USD. The stock has fluctuated within a day range of 40.74 USD to 42.10 USD, while its 52-week range spans from 22.29 USD to 42.81 USD.
What Is XOMA (XOMA) Price Target According to Analysts?
The average 12-month price target for XOMA is 62.00 USD, with a high estimate of 97 USD and a low estimate of 39 USD. 2 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Buy. The stock has an +51.74% Upside potential.
What Is the XOMA Premarket Price?
XOMA's last pre-market stock price is 41.17 USD. The pre-market share volume is 100.00, and the stock has decreased by 0.31, or 0.76%.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2026 - Fusion Media Limited. All Rights Reserved.